Text Size
12 studies found for:    Open Studies | "Pneumococcal Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar 13 (PVC13)
2 Not yet recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumococcal Infections;   MDR Organisms - Nosocomial Pneumonia
Interventions: Drug: Colistimethate (Colistin)Sodium-Aerosolized;   Drug: Colistimethate (Colistin)Sodium-Intravenous
3 Unknown † Early Versus Delayed Pneumococcal Vaccination in HIV
Condition: Pneumococcal Infections
Interventions: Biological: Pneumovax or Pneumo23;   Biological: Prevnar
4 Not yet recruiting Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine
5 Unknown † PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
Conditions: Middle Ear Effusion;   Tympanic Membrane Perforation;   Acute Otitis Media;   Pneumococcal Infections
Intervention: Biological: 23 valent pneumococcal polysaccharide vaccine
6 Unknown † PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
Conditions: Middle Ear Effusion;   Tympanic Membrane Perforation;   Acute Otitis Media;   Pneumococcal Infections
Intervention: Biological: 23vPPV, dTpa (Pneumovax, Boostrix)
7 Not yet recruiting Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar13 (manufactured by Pfizer)
8 Not yet recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
Conditions: Invasive Diseases;   Pneumonia and Acute Otitis Media (AOM) Caused by Streptococcus Pneumoniae
Intervention: Biological: Synflorix™
9 Not yet recruiting Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) in the Young and Elderly
Condition: Pneumococcal Infection
Intervention: Biological: PNEUMOVAX
10 Recruiting Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Conditions: Seizures;   Pneumococcal Meningitis
Interventions: Drug: Phenytoin;   Drug: placebo
11 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
12 Not yet recruiting Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
Condition: Community-acquired Pneumonia
Intervention: Procedure: Observation
To Top

† Indicates status has not been verified in more than two years